Literature DB >> 18384478

ST2859 serogroup A meningococcal meningitis outbreak in Nouna Health District, Burkina Faso: a prospective study.

A Sié1, V Pflüger, B Coulibaly, J P Dangy, A Kapaun, T Junghanss, G Pluschke, J Leimkugel.   

Abstract

We analysed cerebrospinal fluid samples from suspected meningitis cases in Nouna Health District, Burkina Faso, during the meningitis seasons of 2004-2006. Serogroup A ST2859 meningococci belonging to the ST5 clonal complex of subgroup III meningococci were the predominant causative agent. ST2859 bacteria were associated with focal outbreaks in the north of the district. While >10% of the population of an outbreak village carried ST2859, the population in the south of the district was predominantly colonised by serogroup Y ST4375 meningococci, which were associated with only sporadic cases of meningitis. Colonisation with the less virulent Y meningococci may interfere with the spread of the ST2859 to the south of the district, but there are concerns that this serogroup A clone may cause a third wave of subgroup III meningococcal disease in the African Meningitis Belt.

Entities:  

Mesh:

Year:  2008        PMID: 18384478     DOI: 10.1111/j.1365-3156.2008.02056.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  17 in total

1.  Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine.

Authors:  Paul A Kristiansen; Fabien Diomandé; Stanley C Wei; Rasmata Ouédraogo; Lassana Sangaré; Idrissa Sanou; Denis Kandolo; Pascal Kaboré; Thomas A Clark; Abdoul-Salam Ouédraogo; Ki Ba Absatou; Charles D Ouédraogo; Musa Hassan-King; Jennifer Dolan Thomas; Cynthia Hatcher; Mamoudou Djingarey; Nancy Messonnier; Marie-Pierre Préziosi; Marc LaForce; Dominique A Caugant
Journal:  Clin Vaccine Immunol       Date:  2011-01-12

2.  Study of a localized meningococcal meningitis epidemic in Burkina Faso: incidence, carriage, and immunity.

Authors:  Judith E Mueller; Seydou Yaro; Berthe-Marie Njanpop-Lafourcade; Aly Drabo; Régina S Idohou; Sita S Kroman; Oumarou Sanou; Serge Diagbouga; Yves Traoré; Lassana Sangaré; Raymond Borrow; Bradford D Gessner
Journal:  J Infect Dis       Date:  2011-10-12       Impact factor: 5.226

3.  Definition and characterization of localised meningitis epidemics in Burkina Faso: a longitudinal retrospective study.

Authors:  Haoua Tall; Stéphane Hugonnet; Philippe Donnen; Michèle Dramaix-Wilmet; Ludovic Kambou; Frank Drabo; Judith E Mueller
Journal:  BMC Infect Dis       Date:  2012-01-05       Impact factor: 3.090

Review 4.  Incidence, carriage and case-carrier ratios for meningococcal meningitis in the African meningitis belt: a systematic review and meta-analysis.

Authors:  Thibaut Koutangni; Halima Boubacar Maïnassara; Judith E Mueller
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

5.  Characterization of vaccine antigens of meningococcal serogroup W isolates from Ghana and Burkina Faso from 2003 to 2009.

Authors:  Emma Ispasanie; Gerd Pluschke; Abraham Hodgson; Ali Sie; Calman MacLennan; Oliver Koeberling
Journal:  F1000Res       Date:  2014-11-03

6.  Emergence of a new epidemic Neisseria meningitidis serogroup A Clone in the African meningitis belt: high-resolution picture of genomic changes that mediate immune evasion.

Authors:  Araceli Lamelas; Simon R Harris; Katharina Röltgen; Jean-Pierre Dangy; Julia Hauser; Robert A Kingsley; Thomas R Connor; Ali Sie; Abraham Hodgson; Gordon Dougan; Julian Parkhill; Stephen D Bentley; Gerd Pluschke
Journal:  mBio       Date:  2014-10-21       Impact factor: 7.867

7.  Nationwide Trends in Bacterial Meningitis before the Introduction of 13-Valent Pneumococcal Conjugate Vaccine-Burkina Faso, 2011-2013.

Authors:  Dinanibè Kambiré; Heidi M Soeters; Rasmata Ouédraogo-Traoré; Isaïe Medah; Lassana Sangare; Issaka Yaméogo; Guetawendé Sawadogo; Abdoul-Salam Ouédraogo; Soumeya Hema-Ouangraoua; Lesley McGee; Velusamy Srinivasan; Flavien Aké; Malika Congo-Ouédraogo; Soufian Sanou; Absatou Ky Ba; Ryan T Novak; Chris Van Beneden
Journal:  PLoS One       Date:  2016-11-10       Impact factor: 3.240

8.  Hierarchical genomic analysis of carried and invasive serogroup A Neisseria meningitidis during the 2011 epidemic in Chad.

Authors:  Kanny Diallo; Kadija Gamougam; Doumagoum M Daugla; Odile B Harrison; James E Bray; Dominique A Caugant; Jay Lucidarme; Caroline L Trotter; Musa Hassan-King; James M Stuart; Olivier Manigart; Brian M Greenwood; Martin C J Maiden
Journal:  BMC Genomics       Date:  2017-05-22       Impact factor: 3.969

9.  Serogroup W135 meningococcal meningitis, Northern Cameroon, 2007-2008.

Authors:  Denis Massenet; Jermias Inrombe; Dave Etienne Mevoula; Pierre Nicolas
Journal:  Emerg Infect Dis       Date:  2009-02       Impact factor: 6.883

10.  The causative pathogen determines the inflammatory profile in cerebrospinal fluid and outcome in patients with bacterial meningitis.

Authors:  Denis Grandgirard; Rahel Gäumann; Boubacar Coulibaly; Jean-Pierre Dangy; Ali Sie; Thomas Junghanss; Hans Schudel; Gerd Pluschke; Stephen L Leib
Journal:  Mediators Inflamm       Date:  2013-06-20       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.